 SOUTH SAN FRANCISCO, Calif., April 06, 2021 GLOBE NEWSWIRE -- Applied Molecular Transport Inc. Nasdaq: AMTI AMT, a clinical-stage biopharmaceutical company, today announced the closing of its previously announced underwritten public offering of 2,875,000 shares of its common stock, which includes the exercise in full of the underwriters option to purchase 375,000 additional shares of its common stock, at a public offering price of 42.00 per share. All of the shares of common stock were offered by AMT. The aggregate gross proceeds to AMT from the offering were approximately 120.8 million, before deducting underwriting discounts and commissions and other offering expenses. 